Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Nolte

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|February 1, 1994
Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaquesC C Tsai, K E Follis, A Sabo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2013
Monitoring rFVIII prophylaxis dosing using global haemostasis assaysM A Al Hawaj, E J Martin, J Venitz, et al.
Archives of Osteoporosis|September 14, 2013
SCOPE: a scorecard for osteoporosis in EuropeJ A Kanis, F Borgström, J Compston, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 17, 2018
Evaluating the thrombin generation profiles of four different rFVIII products in FVIII-deficient plasma using FIXa and FXIa activationDonald F Brophy, Erika J Martin, Marisa Ninivaggi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2011
Monitoring rFVIIa 90 μg kg⁻¹ dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 hD F Brophy, E J Martin, J Christian Barrett, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2019
Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmasSunita Patel-Hett, Erika J Martin, Bassem M Mohammed, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 28, 2017
Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V-stabilizing fabD F Brophy, E J Martin, B M Mohammed, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2015
Coated platelets and severe haemophilia A bleeding phenotype: Is there a connection?K K Lastrapes, B M Mohammed, M A Mazepa, et al.
Radiation and Environmental Biophysics|April 5, 2008
Intercomparison study on (152)Eu gamma ray and (36)Cl AMS measurements for development of the new Hiroshima-Nagasaki Atomic Bomb Dosimetry System 2002 (DS02)M Hoshi, S Endo, K Tanaka, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver diseaseR K Sterling, C D Lyons, R T Stravitz, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|February 1, 1994
Preexposure prophylaxis with 9-(2-phosphonylmethoxyethyl)adenine against simian immunodeficiency virus infection in macaquesC C Tsai, K E Follis, A Sabo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2013
Monitoring rFVIII prophylaxis dosing using global haemostasis assaysM A Al Hawaj, E J Martin, J Venitz, et al.
Archives of Osteoporosis|September 14, 2013
SCOPE: a scorecard for osteoporosis in EuropeJ A Kanis, F Borgström, J Compston, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 17, 2018
Evaluating the thrombin generation profiles of four different rFVIII products in FVIII-deficient plasma using FIXa and FXIa activationDonald F Brophy, Erika J Martin, Marisa Ninivaggi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2011
Monitoring rFVIIa 90 μg kg⁻¹ dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 hD F Brophy, E J Martin, J Christian Barrett, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 24, 2019
Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmasSunita Patel-Hett, Erika J Martin, Bassem M Mohammed, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 28, 2017
Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V-stabilizing fabD F Brophy, E J Martin, B M Mohammed, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 13, 2015
Coated platelets and severe haemophilia A bleeding phenotype: Is there a connection?K K Lastrapes, B M Mohammed, M A Mazepa, et al.
Radiation and Environmental Biophysics|April 5, 2008
Intercomparison study on (152)Eu gamma ray and (36)Cl AMS measurements for development of the new Hiroshima-Nagasaki Atomic Bomb Dosimetry System 2002 (DS02)M Hoshi, S Endo, K Tanaka, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver diseaseR K Sterling, C D Lyons, R T Stravitz, et al.
Pageof 8